Crescent Biopharma, Inc. (CBIO)
NASDAQ: CBIO · Real-Time Price · USD
11.60
-0.14 (-1.19%)
At close: Feb 20, 2026, 4:00 PM EST
11.65
+0.05 (0.43%)
After-hours: Feb 20, 2026, 7:48 PM EST
Crescent Biopharma Market Cap
Crescent Biopharma has a market cap or net worth of $227.75 million as of February 20, 2026.
Market Cap
227.75M
Enterprise Value
230.47M
1-Year Change
n/a
Ranking
Category
Stock Price
$11.60
Market Cap Chart
Since June 16, 2025, Crescent Biopharma's market cap has decreased from $308.79M to $227.75M, a decrease of -26.24%. That is a compound annual growth rate of -35.99%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 20, 2026 | 227.75M | -1.77% |
| Dec 31, 2025 | 231.86M | -24.91% |
| Jun 16, 2025 | 308.79M | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Silence Therapeutics | 236.17M |
| Sol-Gel Technologies | 233.95M |
| Opus Genetics | 233.79M |
| Prelude Therapeutics | 229.06M |
| MediWound | 229.01M |
| Surrozen | 227.91M |
| Achieve Life Sciences | 227.31M |
| Camp4 Therapeutics | 225.16M |